Overview

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study is to determine the efficacy and safety of 3% or 5% DA-6034 eye drops compared with placebo in dry eye syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Dong-A ST Co., Ltd.
Treatments:
Ophthalmic Solutions
Tetrahydrozoline